137 related articles for article (PubMed ID: 34397934)
1. The potential value of microRNA-145 for predicting prognosis in patients with ovarian cancer: A protocol for systematic review and meta-analysis.
Chen Z; Xiao Z; Zeng S; Yan Z
Medicine (Baltimore); 2021 Aug; 100(32):e26922. PubMed ID: 34397934
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-182 is a potential biomarker for prognosis of gastric cancer: A protocol for meta-analysis and bioinformatics analysis.
Xiao D; Xie J; Wu S
Medicine (Baltimore); 2021 Jun; 100(22):e25830. PubMed ID: 34087825
[TBL] [Abstract][Full Text] [Related]
3. Potential value of MicroRNA-21 as a biomarker for predicting the prognosis of patients with breast cancer: A protocol for meta-analysis and bioinformatics analysis.
Ding Y; Wu W; Ma Z; Shao X; Zhang M; Wang Z
Medicine (Baltimore); 2021 Jun; 100(22):e25964. PubMed ID: 34087839
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of miRNA-126 on in-stent restenosis in patients with coronary heart disease: A protocol for meta-analysis and bioinformatics analysis.
Qiu X; Wang J; Shi Z; Ji X; Huang Y; Dai H
Medicine (Baltimore); 2021 Jun; 100(22):e25887. PubMed ID: 34087832
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA as a biomarker for the prognosis of ischemic stroke: A protocol for meta-analysis and bioinformatics analysis.
Fu J; Yu Q; Xiao J; Li S
Medicine (Baltimore); 2021 Apr; 100(17):e25596. PubMed ID: 33907110
[TBL] [Abstract][Full Text] [Related]
6. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
Li Y; Li L
J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
[TBL] [Abstract][Full Text] [Related]
7. Expression and clinical significance of pyruvate kinase M2 in breast cancer: A protocol for meta-analysis and bioinformatics validation analysis.
Li H; Yan M; Wu X; Wang Y; Huang L
Medicine (Baltimore); 2021 May; 100(18):e25545. PubMed ID: 33950928
[TBL] [Abstract][Full Text] [Related]
8. Potential value of tripartite motif-containing 59 as a biomarker for predicting the prognosis of patients with lung cancer: A protocol for systematic review and meta-analysis.
Guo J; Min K; Deng L
Medicine (Baltimore); 2021 Aug; 100(32):e26868. PubMed ID: 34397900
[TBL] [Abstract][Full Text] [Related]
9. Prospective pathway signaling and prognostic values of MicroRNA-9 in ovarian cancer based on gene expression omnibus (GEO): a bioinformatics analysis.
Zuo L; Li X; Tan Y; Zhu H; Xiao M
J Ovarian Res; 2021 Feb; 14(1):29. PubMed ID: 33563317
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of microRNA-21 in epithelial ovarian carcinoma: A protocol for systematic review and meta analysis.
Ji K; Wang X; Zhang A; Wen H
Medicine (Baltimore); 2020 Dec; 99(52):e23849. PubMed ID: 33350775
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA as a potential biomarker for prognosis of glioma: A protocol for systematic review and meta-analysis.
Xie T; Li B; Liu H; Zhang C; Wang Y; Chen Z; Yan J
Medicine (Baltimore); 2021 Aug; 100(33):e26921. PubMed ID: 34414948
[TBL] [Abstract][Full Text] [Related]
12. miRNA expression profile changes in the peripheral blood of monozygotic discordant twins for epithelial ovarian carcinoma: potential new biomarkers for early diagnosis and prognosis of ovarian carcinoma.
Tuncer SB; Erdogan OS; Erciyas SK; Saral MA; Celik B; Odemis DA; Turkcan GK; Yazici H
J Ovarian Res; 2020 Aug; 13(1):99. PubMed ID: 32854743
[TBL] [Abstract][Full Text] [Related]
13. The Role of PDZ Binding Kinase as a Potential Prognostic and Diagnostic Biomarker in Ovarian Cancer.
Li C; Lyu Y; Liu C; Yin S
Cancer Biother Radiopharm; 2022 Sep; 37(7):569-579. PubMed ID: 33794097
[No Abstract] [Full Text] [Related]
14. Four genes relevant to pathological grade and prognosis in ovarian cancer.
Pan X; Chen Y; Gao S
Cancer Biomark; 2020; 29(2):169-178. PubMed ID: 32444534
[TBL] [Abstract][Full Text] [Related]
15. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
16. Data Mining of Differentially Expressed Genes in Ovarian Epithelial Carcinoma: Implications in Precise Medicine.
Zhao J; Gao H; He Y
Curr Top Med Chem; 2021 Oct; 21(14):1285-1300. PubMed ID: 34238161
[TBL] [Abstract][Full Text] [Related]
17. MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer.
Xu H; Zou R; Li F; Liu J; Luan N; Wang S; Zhu L
Cancer Med; 2021 Jun; 10(11):3655-3673. PubMed ID: 33934540
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of long noncoding RNA urothelial carcinoma-associated 1 in esophageal carcinoma: A protocol for meta-analysis, TCGA data and bioinformatics analysis.
Zhang H; Tian J; Tang J; Wang T
Medicine (Baltimore); 2021 Apr; 100(16):e25452. PubMed ID: 33879677
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA taurine-up regulated gene 1 for the prognosis of osteosarcoma: A protocol for meta-analysis and bioinformatics analysis.
Ren Z; Li C; Gan Y; Liu X; Liang F
Medicine (Baltimore); 2021 Jun; 100(24):e26182. PubMed ID: 34128849
[TBL] [Abstract][Full Text] [Related]
20. The value of Angipoietin-2 as a biomarker for the prognosis of osteosarcoma: A protocol for systematic review and meta-analysis.
Liu L; Zhang X; Li C; Qu Y
Medicine (Baltimore); 2021 Aug; 100(32):e26923. PubMed ID: 34397935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
